Literature DB >> 24365209

Reliability of the walking energy cost test and the six-minute walk test in boys with Duchenne muscular dystrophy.

J C E Kempen1, J Harlaar1, A J van der Kooi2, I J M de Groot3, J C van den Bergen4, E H Niks4, J J G M Verschuuren4, M A Brehm5.   

Abstract

The walking energy cost test (WECT) is a useful tool when measuring ambulatory function in children with motor disorders. However, data on the reliability of this test in Duchenne muscular dystrophy (DMD) is not available. In this study we established the reliability of the WECT and the commonly used six-minute walk test (6MWT) in 19 boys with DMD, aged 6-12years. Participants performed the WECT and 6MWT twice within three weeks. Reliability was determined for walking distance (D, m) and gross energy cost (EC, Jkg(-1)m(-1)), using the intraclass correlation coefficient (ICC2,1) and smallest detectable change (SDC). Reliability for walking distance was good, with an ICC of 0.92 [95% CI: 0.81-0.97] and 0.83 [CI: 0.53-0.94] for the 6MWT and WECT, respectively, and an ICC of 0.85 [CI: 0.64-0.94] for gross EC. SDCs were 12.2% for D6MWT, 12.7% for DWECT and 18.5% for gross EC. In conclusion, in young boys with DMD, the reliability of both the WECT and 6MWT for assessing walking distance is adequate. Gross EC, as assessed with the WECT is also reliable and sufficiently sensitive to detect change in walking strain following interventions at group level.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Duchenne muscular dystrophy; Energy cost of walking test; Reliability; Six minute walking test; Walking ability

Mesh:

Year:  2013        PMID: 24365209     DOI: 10.1016/j.nmd.2013.11.015

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  5 in total

1.  Ankle-Foot Orthosis in Duchenne Muscular Dystrophy: A 4 year Experience in a Multidisciplinary Neuromuscular Disorders Clinic.

Authors:  Anupam Gupta; Atchayaram Nalini; Shanti Prakash Arya; Seena Vengalil; Meeka Khanna; Rashmi Krishnan; Arun B Taly
Journal:  Indian J Pediatr       Date:  2016-11-05       Impact factor: 1.967

2.  Age-related longitudinal changes in metabolic energy expenditure during walking in boys with Duchenne muscular dystrophy.

Authors:  Merel-Anne Brehm; Jiska C E Kempen; Anneke J van der Kooi; Imelda J M de Groot; Janneke C van den Bergen; Jan J G M Verschuuren; Erik H Niks; Jaap Harlaar
Journal:  PLoS One       Date:  2014-12-15       Impact factor: 3.240

3.  Extensive Functional Evaluations to Monitor Aerobic Training in Becker Muscular Dystrophy: A Case Report.

Authors:  Caterina Tramonti; Bruno Rossi; Carmelo Chisari
Journal:  Eur J Transl Myol       Date:  2016-06-13

Review 4.  The burden, epidemiology, costs and treatment for Duchenne muscular dystrophy: an evidence review.

Authors:  S Ryder; R M Leadley; N Armstrong; M Westwood; S de Kock; T Butt; M Jain; J Kleijnen
Journal:  Orphanet J Rare Dis       Date:  2017-04-26       Impact factor: 4.123

5.  Blood-derived biomarkers correlate with clinical progression in Duchenne muscular dystrophy.

Authors:  Kristin Strandberg; Burcu Ayoglu; Andreas Roos; Mojgan Reza; Erik Niks; Mirko Signorelli; Erik Fasterius; Fredrik Pontén; Hanns Lochmüller; Joana Domingos; Pierpaolo Ala; Francesco Muntoni; Annemieke Aartsma-Rus; Pietro Spitali; Peter Nilsson; Cristina Al-Khalili Szigyarto
Journal:  J Neuromuscul Dis       Date:  2020
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.